CAS 1195768-06-9 appears in our catalog under these names: Dabrafenib Mesylate, Dabrafenib Mesylate, >95% (HPLC), Dabrafenib Mesilate, Dabrafenib Mesylate (GSK–2118436), Dabrafenib Mesylate/ 99.62% (existing batch purity). Offered by: Chemat Brand, TRC, Mikromol, GLPBio, TargetMol. Available pack sizes: on request, 10mg, 500mg, 250mg, 100mg, 10mM (in 1ml dmso), 50mg, 5mg.
Dabrafenib mesylate is a methanesulfonate (mesylate) salt prepared from equimolar amounts of dabrafenib and methanesulfonic acid. Used for treatment of metastatic melanoma. It has a role as an antineoplastic agent and a B-Raf inhibitor. It contains a dabrafenib.
Source: ChEBI
| Molecular formula | C24H24F3N5O5S3 |
|---|---|
| Molecular weight | 615.7 g/mol |
| IUPAC name | N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;methanesulfonic acid |
| InChIKey | YKGMKSIHIVVYKY-UHFFFAOYSA-N |
| SMILES | CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F.CS(=O)(=O)O |
Computed by PubChem (NCBI)